Financial Partners Group (Kansas)’s iShares Biotechnology ETF IBB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,251	Closed	-$306K	–	177
2023 Q4	$306K	Hold	2,251	–	–	0.05%	128
2023 Q3	$259K	Sell	2,251 -110	-5%	-$14K	0.05%	130
2023 Q2	$301K	Sell	2,361 -36	-2%	-$4.68K	0.06%	120
2023 Q1	$310K	Sell	2,397 -52	-2%	-$6.81K	0.07%	119
2022 Q4	$329K	Buy	+2,449	New	+$316K	0.07%	120
2022 Q2	–	Sell	-2,356	Closed	-$307K	–	159
2022 Q1	$307K	Sell	2,356 -28,818	-92%	-$3.75M	0.07%	129
2021 Q4	$4.11M	Buy	31,174 +609	+2%	+$94.3K	0.9%	28
2021 Q3	$4.94M	Sell	30,565 -605	-2%	-$102K	1.16%	23
2021 Q2	$5.1M	Sell	31,170 -14,400	-32%	-$2.22M	1.31%	20
2021 Q1	$6.86M	Sell	45,570 -816	-2%	-$130K	1.95%	15
2020 Q4	$7.59M	Sell	46,386 -2,272	-5%	-$325K	2.27%	15
2020 Q3	$6.59M	Sell	48,658 -562	-1%	-$76.2K	2.26%	15
2020 Q2	$6.73M	Buy	49,220 +15,578	+46%	+$1.99M	2.63%	13
2020 Q1	$3.49M	Buy	33,642 +1,892	+6%	+$218K	2.16%	15
2019 Q4	$3.73M	Sell	31,750 -171	-0.5%	-$19.1K	1.45%	18
2019 Q3	$3.18M	Buy	+31,921	New	+$3.34M	1.41%	19
2019 Q2	–	Sell	-25,802	Closed	-$2.88M	–	80
2019 Q1	$2.88M	Sell	25,802 -9,371	-27%	-$1.03M	1.56%	21
2018 Q4	$3.39M	Buy	35,173 +1,889	+6%	+$200K	2.21%	15
2018 Q3	$4.06M	Sell	33,284 -607	-2%	-$71.5K	2.65%	13
2018 Q2	$3.72M	Buy	33,891 +398	+1%	+$42.6K	2.73%	11
2018 Q1	$3.58M	Sell	33,493 -679	-2%	-$75.3K	2.8%	13
2017 Q4	$3.65M	Buy	+34,172	New	+$3.65M	2.88%	13